{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T07:09:03Z","timestamp":1786950543699,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008092","name":"Jinhua City Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023-1-120"],"award-info":[{"award-number":["2023-1-120"]}],"id":[{"id":"10.13039\/501100008092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018552","name":"Science and Technology Plan Project of Taizhou","doi-asserted-by":"publisher","award":["24gya05"],"award-info":[{"award-number":["24gya05"]}],"id":[{"id":"10.13039\/501100018552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LHDMZ24H300003"],"award-info":[{"award-number":["LHDMZ24H300003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","award":["2024TZSX105"],"award-info":[{"award-number":["2024TZSX105"]}],"id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejpb.2025.114940","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:42:09Z","timestamp":1764088929000},"page":"114940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A novel histidine-acetate buffer for freeze-dried monoclonal antibody formulations"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4757-1065","authenticated-orcid":false,"given":"Jia-Yi","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Jia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jie","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114940_b0005","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/0929866523666161222150444","article-title":"Protein and peptide biopharmaceuticals: an overview","volume":"24","author":"Agyei","year":"2017","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.ejpb.2025.114940_b0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11095-024-03657-7","article-title":"The effects of excipients on freeze-dried monoclonal antibody formulation degradation and sub-visible particle formation during shaking","volume":"41","author":"Jin","year":"2024","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114940_b0015","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.xphs.2017.11.015","article-title":"Arginine as an excipient for protein freeze-drying: a mini review","volume":"107","author":"St\u00e4rtzel","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114940_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124472","article-title":"Histidine as a versatile excipient in the protein-based biopharmaceutical formulations","author":"Lv","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114940_b0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1208\/s12248-024-01009-2","article-title":"Formulation factors affecting the formation of visible-bubbles during the reconstitution process of freeze-dried etanercept formulations: protein concentration, stabilizers, and surfactants","volume":"27","author":"Gao","year":"2025","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2025.114940_b0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijpharm.2014.01.002","article-title":"Stabilisation of proteins via mixtures of amino acids during spray drying","volume":"463","author":"Ajmera","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114940_b0035","first-page":"13","article-title":"Practical advice in the development of a lyophilized protein drug product","volume":"8","author":"Cheng","year":"2025","journal-title":"Antib. Ther."},{"key":"10.1016\/j.ejpb.2025.114940_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124974","article-title":"Effects of buffers on spray-freeze-dried\/lyophilized high concentration protein formulations","volume":"668","author":"Patil","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114940_b0045","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1023\/B:PHAM.0000008042.15988.c0","article-title":"Influence of histidine on the stability and physical properties of a fully human antibody in aqueous and solid forms","volume":"20","author":"Chen","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2025.114940_b0050","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1208\/s12249-011-9747-2","article-title":"Biotherapeutic formulation factors affecting metal leachables from stainless steel studied by design of experiments","volume":"13","author":"Zhou","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2025.114940_b0055","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.xphs.2020.12.009","article-title":"The influence of arginine and counter-ions: antibody stability during freeze-drying","volume":"110","author":"Seifert","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114940_b0060","first-page":"265","article-title":"Effects of arginine in therapeutic protein formulations: a decade review and perspectives","volume":"6","author":"Ren","year":"2023","journal-title":"Antib. Ther."},{"key":"10.1016\/j.ejpb.2025.114940_b0065","unstructured":"J.D. Andya, J.L. Cleland, C.C. Hsu, X.M. Lam, D.E. Overcashier, S.J. Shire, J.Y.-F. Yang, S.S.Y. Wu. Protein formulation. US Patent 9,283,273 B2, 23 Mar 2010."},{"key":"10.1016\/j.ejpb.2025.114940_b0070","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2074149","article-title":"Improved stability of a model IgG3 by DoE\u2010based evaluation of buffer formulations","volume":"2016","author":"Chavez","year":"2016","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ejpb.2025.114940_b0075","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1002\/jps.21232","article-title":"Self-buffering antibody formulations","volume":"97","author":"Gokarn","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.ejpb.2025.114940_b0080","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1080\/19420862.2017.1368602","article-title":"Forced degradation of recombinant monoclonal antibodies: a practical guide","volume":"9","author":"Nowak","year":"2017","journal-title":"MAbs"},{"key":"10.1016\/j.ejpb.2025.114940_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apcsb.2018.01.005","article-title":"Rational design of liquid formulations of proteins","volume":"112","author":"Manning","year":"2018","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.ejpb.2025.114940_b0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fchem.2018.00004","article-title":"Detection of collapse and crystallization of saccharide, protein, and mannitol formulations by optical fibers in lyophilization","volume":"6","author":"Horn","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejpb.2025.114940_b0095","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1021\/acs.molpharmaceut.3c00991","article-title":"Effect of annealing on visible-bubble formation and stability profiles of freeze-dried high concentration omalizumab formulations","volume":"21","author":"Gao","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114940_b0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/abbi.1996.0305","article-title":"Physical factors affecting the storage stability of freeze-dried interleukin-1 receptor antagonist: glass transition and protein conformation","volume":"331","author":"Chang","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejpb.2025.114940_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203819","article-title":"Role of simple descriptors and applicability domain in predicting change in protein thermostability","volume":"13","author":"McGuinness","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2025.114940_b0110","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2024.2403156","article-title":"A comparative study of the developability of full-length antibodies, fragments, and bispecific formats reveals higher stability risks for engineered constructs","volume":"16","author":"Condado-Morales","year":"2024","journal-title":"MAbs"},{"key":"10.1016\/j.ejpb.2025.114940_b0115","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1002\/jps.21617","article-title":"Characterization of the photodegradation of a human IgG1 monoclonal antibody formulated as a high\u2010concentration liquid dosage form","volume":"98","author":"Qi","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114940_b0120","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jps.20815","article-title":"Protect from light: photodegradation and protein biologics","volume":"96","author":"Kerwin","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114940_b0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1039\/c1pp05164d","article-title":"Photo-oxidation of proteins","volume":"11","author":"Pattison","year":"2012","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.ejpb.2025.114940_b0130","first-page":"5","article-title":"Aggregation of monoclonal antibody products: formation and removal","volume":"26","author":"Joshi","year":"2013","journal-title":"BioPharm Int."},{"key":"10.1016\/j.ejpb.2025.114940_b0135","doi-asserted-by":"crossref","first-page":"12780","DOI":"10.1039\/D1CP01573G","article-title":"A coarse-grained xDLVO model for colloidal protein\u2013protein interactions","volume":"23","author":"Pusara","year":"2021","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ejpb.2025.114940_b0140","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0301-4622(01)00214-9","article-title":"Probing hydration and the stability of protein solutions\u2014a colloid science approach","volume":"93","author":"Rowe","year":"2001","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.ejpb.2025.114940_b0145","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1021\/acs.molpharmaceut.3c00403","article-title":"Lysozyme\u2013sucrose interactions in the solid state: glass transition, denaturation, and the effect of residual water","volume":"20","author":"Bogdanova","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114940_b0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejpb.2018.07.011","article-title":"Parenteral protein formulations: an overview of approved products within the European Union","volume":"131","author":"Gervasi","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114940_b0155","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpharm.2006.10.037","article-title":"Spectroscopic evaluation of the stabilization of humanized monoclonal antibodies in amino acid formulations","volume":"335","author":"Tian","year":"2007","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125003182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125003182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T10:23:12Z","timestamp":1766139792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125003182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"alternative-id":["S0939641125003182"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114940","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel histidine-acetate buffer for freeze-dried monoclonal antibody formulations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114940"}}